Bone density in myasthenia gravis patients receiving long-term prednisolone therapy

Clinical Neurology and Neurosurgery

Volumn 106, Issue 2, 2004, Pages 139-141

  Wakata, Nobuo ^a   Nemoto, Hiroshi ^a   Sugimoto, Hideki ^a   Nomoto, Nobuatu ^a   Konno, Shingo ^a   Hayashi, Norihide ^a   Araki, You ^a   Nakazato, Atushi ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Bone density; CXD method; Deoxypyridinoline; DX method; Myasthenia gravis; Osteoporosis

Indexed keywords

CREATININE; DEOXYPYRIDINOLINE; ELCATONIN; PREDNISOLONE;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE RADIOGRAPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; LONG TERM CARE; MALE; MYASTHENIA GRAVIS; OSTEOLYSIS; OSTEOPOROSIS; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BONE DENSITY; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; LONG-TERM CARE; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; OSTEOPOROSIS; PREDNISOLONE; RECEPTORS, CHOLINERGIC; RISK;

EID: 1542319260     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2003.12.001     Document Type: Article

References (11)

1. Lewis S.J.G., Smith P.E.M. Osteoporosis prevention in myasthenia gravis: a reminder. Acta. Neurol. Scand. 103:2001;320-322.
2. Lloyd M.E., Howard R., Scott F., D T. Bone density in steroid treated patients with myasthenia gravis. J. Neurol. Neurosurg. Psychiatr. 64:1998;702. [abstract].
3. Smith G.D.P., Stevens D.L., N G. Myasthenia gravis, corticosteroids and osteoporosis prophylaxis. J. Neurol. 248:2001;151.
4. Inoue T., Kusida K., Miyamoto S., Sumi Y., Orimo H., Yamashita G. Quantitative assessment of bone density on X-ray picture. J. Jpn. Orthop. Assoc. 57:1983;1923-1936.
5. Matsumoto C., Kushida K., Yamazaki K., Imose K., Inoue T. Metacarpal bone mass in normal and osteoporotic Japanese women using computed X-ray densitometry. Calcif. Tissue Int. 55:1994;324-329.
6. Taniguchi M., Kushida K., Denda M., Fujiwara T., Inoue T. A study of 2nd metacarpal bone mineral density by dual energy X-ray absorptiometry. Cent. Jpn. J. Orthop. Trauma. 33:1989;870-971. [in Japanese].
7. Orimo H., Sugioka Y., Fukunaga J., Hotokebuchi T., Gorai I., Nakamura T.et al. Primary osteoporosis and diagnostic standard. Osteopor. Jpn. 4:1996;643-653. [in Japanese].
8. Orimo H., Hayashi M., Fukunaga J., Sone T., Fujiwara S., Shiraki M.et al. Diagnostic criteria in primary osteoporosis. Osteopor. Jpn. 10:2002;7-79. [in Japanese].
9. Jacobson M.E. The rationale of alternate-day corticosteroid therapy. Postgrad. Med. 49:1971;181-186.
10. Lloyd M.E., Spector T.D., Howard R. Osteoporosis in neurological disorders. J. Neurol. Neurosurg. Psychiatr. 68:2000;543-549.
11. The National Osteoporosis Society: guidance on the prevention and management of corticosteroid induced osteoporosis. National Osteoporosis Society, Bath, 1999.